天然致幻剂的危害及滥用的预防

致幻剂是能使人产生致幻作用,出现视幻觉、听幻觉,经常使用能使人形成依赖性,对身体造成危害的物质.我国存在着很多天然致幻剂资源,常见的有乌羽玉、致幻蘑菇.曼陀罗、肉豆蔻、小韶子.研究这几种常见天然致幻剂对人体的危害,提出相应的防治对策,防止天然致幻剂的滥用,具有重要意义.     

苯环利定类新型致幻剂的分析方法研究进展

苯环利定是一种人工合成的新精神活性物质，具有强烈的致幻作用，吸食后暴力倾向增加，该物质在受到管制后大量结构类似物被合成，严重威胁公众健康和社会安定。苯环利定类新型致幻剂滥用引起了国际社会的广泛关注，对其药理毒理及分析方法的研究成为法医毒物分析领域的热点。结合近几年的研究，本文综述了苯环利定类新型致幻剂的理化性质、药理毒理作用、体内过程及检测方法，以期为苯环利定类新型致幻剂的监测管控提供依据。     

新型毒品2C-B的研究进展

2C-B是一种新型的毒品,它具有兴奋和致幻的双重精神作用。作为滥用品始于上世纪80年代的欧美地区,近年来,在一些亚洲国家和地区包括我国开始出现其滥用的情况,并有逐渐增多的趋势。本文就2C-B的合成方法、药毒理作用、代谢等方面进行综述。     

氯胺酮滥用的研究进展

氯胺酮为非竞争性NMDA受体阻断剂,作为一种分离性麻醉药应用于临床,其作用机制复杂,由于其具有一定的致幻作用而被滥用于各种娱乐场所,是目前药物滥用中的一个新问题。本文在阐述氯胺酮的药理学及毒理学特性的基础上,复习了氯胺酮与NMDA受体、多巴胺受体等神经生物学相关受体的相互作用,综述氯胺酮滥用的现状、滥用的可能生理机制及其滥用后的检测方法等方面的研究进展。     

有毒生物碱阿托品的检验现状

阿托品是一种抗胆碱药,可用于有机磷农药中毒的抢救,但因其本身具有毒性和致幻性,常被滥用并导致中毒甚至死亡,又可被添加至可卡因等毒品中。目前,阿托品的主要检测方法有气相色谱、液相色谱和毛细管电泳,本文综述了这几种方法检测阿托品的现状。     

3种哌嗪类药物滥用研究进展

哌嗪类药物N-苄基哌嗪(BZP)、1-(3-氯苯基)哌嗪(mCPP)、1-(3-三氟甲基苯基)哌嗪(TFMPP)具有与MDMA相似的兴奋作用和致幻作用,成了迷幻药的替代品,在各国滥用的报道逐年增多。本文综述了3种哌嗪类药物在各国的管制、滥用情况、毒理作用、检测方法,希望为司法部门打击此类药物犯罪提供参考和借鉴。     

合成大麻素检验方法研究进展

近年合成大麻素类物质(synthetic cannabinoids,SCs)的危害及滥用引起社会广泛关注,它们不仅具有类似天然大麻的致幻性,还有更强的副作用,包括潜在的神经精神毒性,严重影响人类身心健康。因此,国内外研究人员对合成大麻素及其代谢物的检验方法进行了相关研究。本文主要介绍了SCs的生理药理作用、主要分类等,对其检验方法研究进展进行了综述与展望,探讨了各检验方法的应用范围与选择依据,以期为SCs相关案件的检验鉴定提供参考。     

合成卡西酮类新精神活性物质对动物行为学影响的研究进展

合成卡西酮类是一类具有与苯丙胺类毒品类似结构的新精神活性物质,服用后可产生与苯丙胺、可卡因等毒品类似的兴奋作用。近年来,国内外合成卡西酮类的滥用现象日趋严峻,对社会治安与公共健康均造成了严重威胁。本文着重探讨几种常见合成卡西酮类物质,归纳其在动物自主活动实验、药物依赖模型实验中的研究结果,总结其在动物体温调节、学习记忆与焦虑方面的相关实验结论,以期为国内开展相关滥用物质研究提供数据借鉴和方法指导。     

滥用起诉权的民事责任

起诉权,是法律赋予民事主体保护其权利的权利。如同任何权利之行使都不可超越法律许可的范围一样,起诉权亦不得滥用。而当前,一种滥用起诉权损害他人利益的行为已引起人们的关注。这种行为的主体并不是为了保护自己的合法权益而诉诸法律,而是利用诉讼活动这一特殊的方式来达到使被告在物质上、精神上蒙受损失的目的。这种行为不仅是毫无必要的,而且也是十分有害的。应通过改善执法和完善立法来遏制这种行为,使之承担相应的法律责任。     

急性汞蒸气吸入中毒1例尸检报告

急性金属汞中毒少见,主要由于意外事故,短时内吸入大量汞蒸气所致.由于滥用含汞偏方治疗疾病引起汞蒸气吸入而致非职业性汞中毒,近年来国内已有少数临床病例报告,但尚未见有尸检报告.作者等曾尸检一例,现报告如下.     

The determination of psilocin and psilocybin in hallucinogenic mushrooms by HPLC utilizing a dual reagent acidic potassium permanganate and tris(2,2'-bipyridyl)ruthenium(II) chemiluminescence detection system

This paper describes a procedure for the determination of psilocin and psilocybin in mushroom extracts using high-performance liquid chromatography with postcolumn chemiluminescence detection. A number of extraction methods for psilocin and psilocybin in hallucinogenic mushrooms were investigated, with a simple methanolic extraction being found to be most effective. Psilocin and psilocybin were extracted from a variety of hallucinogenic mushrooms using methanol. The analytes were separated on a C12 column using a (95:5% v/v) methanol:10 mM ammonium formate, pH 3.5 mobile phase with a run time of 5 min. Detection was realized through a dual reagent chemiluminescence detection system of acidic potassium permanganate and tris(2,2'-bipyridyl)ruthenium(II). The chemiluminescence detection system gave improved detectability when compared with UV absorption at 269 nm, with detection limits of 1.2 x 10(-8) and 3.5 x 10(-9) mol/L being obtained for psilocin and psilocybin, respectively. The procedure was applied to the determination of psilocin and psilocybin in three Australian species of hallucinogenic mushroom.     

Forensic analysis of hallucinogenic fungi: a DNA-based approach

Hallucinogenic fungi synthesize two controlled substances, psilocin and psilocybin. Possession of the fungal species that contain these compounds is a criminal offence in North America. Some related species that are morphologically similar, do not contain the controlled substances. Therefore, unambiguous identification of fungi to the species level is critical in determining if a mushroom is illegal. We investigate a phylogenetic approach for the identification of species that contain the psychoactive compounds. We analyzed 35 North American specimens representing seven different genera of hallucinogenic and non-hallucinogenic mushrooms. We amplified and sequenced the internal transcribed spacer region of the rDNA (ITS-1) and a 5' portion of the nuclear large ribosomal subunit of rRNA (nLSU rRNA or 28S). ITS-1 locus sequence data was highly variable and produced a phylogenetic resolution that was not consistent with morphological identifications. In contrast, the nLSU rRNA data clustered isolates from the same species and separated hallucinogen containing and non-hallucinogen containing isolates into distinct clades. With this information, we propose an approach that combines the specificity of PCR detection and the resolving power of phylogenetic analysis to efficiently and unambiguously identify hallucinogenic fungal specimens for legal purposes.     

Forensic analysis of hallucinogenic fungi: a DNA-based approach

Hallucinogenic fungi synthesize two controlled substances, psilocin and psilocybin. Possession of the fungal species that contain these compounds is a criminal offence in North America. Some related species that are morphologically similar, do not contain the controlled substances. Therefore, unambiguous identification of fungi to the species level is critical in determining if a mushroom is illegal. We investigate a phylogenetic approach for the identification of species that contain the psychoactive compounds. We analyzed 35 North American specimens representing seven different genera of hallucinogenic and non-hallucinogenic mushrooms. We amplified and sequenced the internal transcribed spacer region of the rDNA (ITS-1) and a 5′ portion of the nuclear large ribosomal subunit of rRNA (nLSU rRNA or 28S). ITS-1 locus sequence data was highly variable and produced a phylogenetic resolution that was not consistent with morphological identifications. In contrast, the nLSU rRNA data clustered isolates from the same species and separated hallucinogen containing and non-hallucinogen containing isolates into distinct clades. With this information, we propose an approach that combines the specificity of PCR detection and the resolving power of phylogenetic analysis to efficiently and unambiguously identify hallucinogenic fungal specimens for legal purposes.     

Morphological and chemical analysis of magic mushrooms in Japan

Morphological and toxicological analyses were performed on hallucinogenic mushrooms that are currently circulated in Japan. Scanning electron microscope (SEM) indicated a three-dimensional microstructures in the mushrooms. The complementary use of SEM with an optical microscope was effective for observing characteristic tissues, such as basidiomycetes, spores, cystidia and basidia. Hallucinogenic alkaloids were extracted with methanol and determined by high performance liquid chromatography (HPLC) with a UV detector set at 220 nm. The psilocin/psilocybin contents in Psilocybe cubensis were in the range of 0.14-0.42%/0.37-1.30% in the whole mushroom (0.17-0.78%/0.44-1.35% in the cap and 0.09-0.30%/0.05-1.27% in the stem), respectively. The hallucinogenic alkaloids in Copelandia were 0.43-0.76%/0.08-0.22% in the whole mushroom (0.64-0.74%/0.02-0.22% in the cap and 0.31-0.78%/0.01-0.39% in the stem). It thus appears that P. cubensis is psilocybin-rich, whereas Copelandia is psilocin-rich.     

Hallucinogenic mushrooms on the German market - simple instructions for examination and identification

'Magic mushrooms' is the name most commonly given to psychoactive fungi containing the hallucinogenic components psilocybin and psilocin. Material confiscated by local authorities was examined using morphologic, microscopic, microchemical, and toxicological methods. Psilocybe cubensis was the most popular mushroom in the sample collective, followed by Psilocybe semilanceata, Panaeolus cyanescens and Psilocybe tampanensis. The alkaloid content was determined with <0.003-1.15% of psilocybin and 0.01-0.90% psilocin. Panaeolus cyanescens was the mushroom with highest levels of psilocybin and psilocin.     

Unpredictable Behavior Under the Influence of “Magic Mushrooms”: A Case Report and Review of the Literature

Fatalities implicating psychedelic mushrooms are not a common clinical situation in everyday forensic medicine. Despite classification as an illegal drug in many countries, psilocybin mushrooms have the reputation of being safe. We report the case of a young man who jumped from a second story balcony under the influence of psilocybin mushrooms. The psilocin assay was performed by gas chromatography coupled to an electron‐impact ionization time‐of‐flight detector (GC‐EI‐TOF) after solid‐phase extraction. Total psilocin was quantified in peripheral and cardiac blood as 60 and 67 ng/mL, respectively, and in urine (2230 ng/mL), bile (3102 ng/mL), and vitreous humor (57 ng/mL). This case report and review of literature highlights the danger of psilocybin mushrooms. Isolated use of psilocybin mushrooms by a regular consumer without psychiatric history, even under “safe” circumstances, can lead to a fatal outcome.     

Detecting psychoactive drugs in the developmental stages of mushrooms

The following questions regarding the detection of psychoactive drugs in mushrooms are addressed: At what stage of the mushroom development can the psychoactive drugs psilocyn and psilocybin be identified, and what effect does light have on the growth of these mushrooms. To answer these questions, Psilocybe cyanescens Wakefield mushrooms were grown from their spores in a controlled setting. At various times of their development, samples were taken and analyzed for psilocyn and psilocybin. Knowing what stage of development the psychoactive drugs can be identified may be useful to law enforcement personnel and forensic chemists. Methanolic extracts of various samples were analyzed by TLC and by GC/MS. It was determined that the mycelium knot stage of the mushroom was the earliest stage at which the psychoactive drugs could be detected. It was observed that light affected the time of development and the appearance of these mushrooms.     

Detection of psilocin in body fluids

Active compounds of some mushrooms e.g. Psilocybe cubensis, Paneolus subalteatus or Stropharia coronilla, the psychotropic agents psilocybin and psilocin, have hallucinogenic effects. In one case of 'magic mushroom' intake, we had to analyse blood and urine. Psilocin was detected in the urine with REMEDi HS. Most of the psilocin was excreted as the glucuronide. Therefore an enzymatic hydrolysis should be the first step in analysis. Free psilocin was determined at a concentration of 0.23 mg/l while the total amount was 1.76 mg/l urine. The concentration of psilocin in serum was too low for detection with REMEDi HS. We proved a GC-MS-method with d(3)-morphine as internal standard and silylation with MSTFA. Similarly to urine, most of the psilocin in serum was found in the conjugated form. The concentration of free psilocin was 0.018 mg/l, that of total psilocin, 0.052 mg/l serum.     

Phylogenetic relationship of psychoactive fungi based on rRNA gene for a large subunit and their identification using the TaqMan assay (II)

"Magic mushroom (MM)" is the name most commonly given to psychoactive fungi containing the hallucinogenic components: psilocin (1) and psilocybin (2). We investigated the rRNA gene (internal transcribed spacer (ITS) and large subunit (LSU)) of two Panaeolus species and four Psilocybe species fungi (of these, two are non-psilocybin species). On the basis of sequence alignment, we improved the identification system developed in our previous study. In this paper, we describe the new system capable of distinguishing MMs from non-psilocybin Psilocybe species, its application data and the phylogeny of MM species.     

Psychedelic fungus (Psilocybe sp.) authentication in a case of illegal drug traffic: sporological,molecular analysis and identification of the psychoactive substance

In nature, there are >200 species of fungi with hallucinogenic properties. These fungi are classified as Psilocybe, Gymnopilus, and Panaeolus which contain active principles with hallucinogenic properties such as ibotenic acid, psilocybin, psilocin, or baeocystin. In Chile, fungi seizures are mainly of mature specimens or spores. However, clandestine laboratories have been found that process fungus samples at the mycelium stage. In this transient stage of growth (mycelium), traditional taxonomic identification is not feasible, making it necessary to develop a new method of study.Currently, DNA analysis is the only reliable method that can be used as an identification tool for the purposes of supporting evidence, due to the high variability of DNA between species. One way to identify the species of a distinctive DNA fragment is to study PCR products analyzed by real time PCR and sequencing. One of the most popular sequencing methods of forensic interest at the generic and intra-generic levels in plants is internal transcribed spacer (ITS). With real time PCR it is possible to distinguish PCR products by differential analysis of their melting temperature (Tm) curves.This paper describes morphological, chemical, and genetic analysis of mycelia of psychedelic fungi collected from a clandestine laboratory. The fungus species were identified using scanning electron microscopy (SEM), mass spectrometry, HRM analysis, and ITS sequencing. The sporological studies showed a generally smooth surface and oval shape, with maximum length 10.1?μm and width 6.4?μm. The alkaloid Psilocyn was identified by mass spectrometry, while HRM analysis and ITS sequencing identified the species as Psilocybe cubensis. A genetic match was confirmed between the HRM curves obtained from the mycelia (evidence) and biological tissue extracted from the fruiting bodies. Mycelia recovered from the evidence and fruiting bodies (control) were genetically indistinguishable.